DUET CD: A Phase 2b Randomized, Double-blind, Active- and Placebo-controlled, Parallel-group, Multicenter Study to Evaluate the Efficacy and Safety of Induction and Maintenance Combination Therapy with Guselkumab and Golimumab in Participants with Moderat

Grants and Contracts Details

StatusActive
Effective start/end date11/14/222/22/25

Funding

  • Janssen Research and Development LLC: $151,178.00